Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Actsita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Edoc Life Sciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Actsita M 50mg/500mg Tablet

Diabexe Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal failure and vision loss, potentially lowering heart attack and stroke risk. Diabexe Duo may be used independently or with other diabetes treatments, maximizing efficacy when coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, factoring in existing health status, blood sugar levels, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time ensures optimal therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; patients should be trained to recognize and manage hypoglycemic episodes. This medication isn't universally suitable. Prior medical history, including kidney, liver, or heart conditions, pancreatic issues, and significant alcohol consumption, should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Inform your doctor of all other medications to avoid potential interactions. Alcohol should be minimized due to its hypoglycemic effect. Kidney function and blood glucose will be monitored regularly throughout treatment.

Uses of Actsita M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Actsita M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Actsita M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Actsita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Actsita M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Actsita M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Actsita M 50mg/500mg Tablet works:

Actsita M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Actsita M 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Actsita M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Actsita M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with kidney impairment, Actsita M 50mg/500mg Tablets require careful administration. Dosage modification may be necessary. Physician consultation is recommended. Actsita M 50mg/500mg Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Actsita M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Actsita M 50mg/500mg Tablet :

Should you forget a dose of Actsita M 50mg/500mg Tablet, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Actsita M 50mg/500mg Tablet

LabelValue
Addictive No.
Treatment Category Diabetes medication

FAQs on Actsita M 50mg/500mg Tablet

Actsita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Actsita M 50mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Actsita M 50mg/500mg Tablet may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Actsita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Actsita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Sitagliptin/Metformin (like Actsita M 50mg/500mg) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Actsita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Actsita M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Actsita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Actsita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/metformin tablets (like Actsita M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Actsita M 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Actsita M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Actsita M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Actsita M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Actsita M 50mg/500mg Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (like Actsita M 50mg/500mg) can cause lactic acidosis, a serious condition with dangerously high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare but potentially life-threatening side effect is why it's avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Actsita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Actsita M 50mg/500mg Tabl...
111